Medtronic reports strongest annual revenue growth in a decade

Medtronic said its growth was driven by ongoing strength in its core business lines and rising momentum within evolving areas. Medtronic said its growth was driven by ongoing strength in its core business lines and rising momentum within evolving areas. Medtronic now expects FY27 growth to fall in 6.75% to 7.25% range on an organic basis, with earnings mooted to fall in the $5.90 to $6.00 per share range. Credit: JHVEPhoto / Shutterstock Medtronic has reported total revenue of $36.4bn in fiscal year 2026 (FY26), a figure the company said reflects the highest annual growth achieved in 10 years. With…

Source: Medical Device Network